Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Proscia’s Growth More Than Doubles As Customers Adopt Enterprise Pathology
-
Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics
-
Augmedix Awarded Vizient Contract for Ambient AI Documentation Solutions
-
BitMine Reports Fiscal 1st Quarter 2025 Financial Results
-
Ashvattha Therapeutics Announces $50 Million Financing Extension and Interim Phase 2 Ophthalmology Trial Results
-
Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025
-
The Chefs’ Warehouse Announces Preliminary Fiscal Year 2025 Guidance
-
LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*
-
Neuronetics Provides Business Update and Issues 2025 Guidance
-
El Pollo Loco Appoints Joe Taylor to its Board of Directors
-
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3
-
Enphase Energy Introduces IQ Battery 5P with FlexPhase, Delivering Three-Phase Backup Power in Germany, Austria, and Switzerland
-
CPI Aerostructures Awarded Lot 4 Production Contract of Next Generation Jammer Mid-Band Program by Raytheon Technologies
-
Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification
-
Werewolf Therapeutics Provides Business Update and Highlights 2025 Strategic Outlook
-
Transpire Bio Announces Progress in Clinical Development with Initiation of a New Human Subject Study for Asthma and COPD Inhaled Drug Program
-
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors
-
Sernova Announces Voting Results from its Annual and Special General Meeting of Shareholders
-
Humacyte Provides Update on Commercial Launch and Pricing of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma
-
Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy
-
Protara Highlights Recent Updates and Anticipated 2025 Milestones
-
Greenridge Exploration Announces Results of its 2024 Exploration Program at its Carpenter Lake Uranium Project in the Athabasca Basin
-
Ekso Bionics Reports Certain Preliminary Fourth Quarter 2024 Financial Results
-
TTM Technologies Honors Community Service with the 2024 TTM Chair of Community Service Award
-
Pointwealth Capital Management Welcomes Glenn Hruska and Expands Assets Under Management to Over $450 Million
-
SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter and Fiscal Year Ended December 31, 2024
-
NV5 Enters Agreement to Acquire Group Delta; Strengthens Southern California Infrastructure Engineering, Testing, and Environmental Services
-
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results
-
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance
-
ORYZON Announces First Patient Dosed in NCI-Sponsored Iadademstat in Combination With Venetoclax and Azacitidine Clinical Trial in First Line Acute Myeloid Leukemia
-
VEON to List Kyivstar on Nasdaq in New York, Signs Letter of Intent with Cohen Circle
-
With Technological Accumulation as the Axis and Brand Execution as the Core, THUNDEROBOT Debuts at CES 2025
-
With Technological Accumulation as the Axis and Brand Execution as the Core, THUNDEROBOT Debuts at CES 2025
-
Jabra Unveils Perform 75, a Purpose-Built Headset for Retail Shiftwork to Boost Collaboration and Productivity
-
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials
-
American Rebel Holdings CEO Andy Ross Performs at Legendary Whiskey Jam Showcase
-
Rezolve Ai Poised for Global Growth as it enters 2025 with Strong Customer Acquisitions, Strategic Partnerships, and Groundbreaking Innovations
-
Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
SRIVARU Limited Holding Announces Effective Time of Share Consolidation/Reverse Share Split to Regain NASDAQ Compliance
-
Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX for First-Line Pancreatic Cancer
-
Denali Therapeutics Announces Key Anticipated 2025 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases
-
Annexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough Year
-
Immunovant Announces $450 Million Private Placement
-
Iantrek Announces First Commercial Cases of its C.Rex Micro-Interventional System for Trabecular Outflow Enhancement
-
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results
-
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference
-
89bio Provides Business Update and Outlook for 2025
-
ARS Pharmaceuticals Announces Preliminary Fourth Quarter 2024 Financial Results and 2025 Objectives for neffy® (epinephrine nasal spray)
-
Extendicare Announces Timing of 2024 Fourth Quarter Results and Conference Call
-
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
